Ditchcarbon
  • Customers
  1. Organizations
  2. CV Sciences, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 3 days ago

CV Sciences, Inc.

Company website

CV Sciences, Inc., a prominent player in the hemp-derived cannabinoid industry, is headquartered in the United States. Founded in 2010, the company has established itself as a leader in the development and distribution of high-quality CBD products, focusing on both consumer wellness and pharmaceutical applications. With a commitment to innovation, CV Sciences offers a range of unique products, including their popular PlusCBD™ Oil line, which is distinguished by its rigorous quality standards and comprehensive testing protocols. The company has achieved significant milestones, including being one of the first to receive Generally Recognized as Safe (GRAS) status for its hemp extracts. Recognised for its market position, CV Sciences continues to expand its operational reach across North America, contributing to the growing acceptance and understanding of hemp-based wellness solutions.

DitchCarbon Score

How does CV Sciences, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

30

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

29

Industry Benchmark

CV Sciences, Inc.'s score of 30 is higher than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.

55%

Let us know if this data was useful to you

CV Sciences, Inc.'s reported carbon emissions

In 2022, CV Sciences, Inc. reported total carbon emissions of approximately 14,472,715,000 kg CO2e across all scopes. This includes 250,022,000 kg CO2e from Scope 1 emissions, which encompass direct emissions from owned or controlled sources, and 786,489,000 kg CO2e from Scope 2 emissions, representing indirect emissions from the generation of purchased electricity, steam, heating, and cooling. The majority of their emissions, about 14,472,715,000 kg CO2e, stem from Scope 3, which includes emissions from the entire value chain, such as purchased goods and services (approximately 12,959,465,000 kg CO2e) and employee commuting (about 437,707,000 kg CO2e). CV Sciences has set ambitious long-term climate commitments, aiming for a 30% reduction in carbon emissions by 2030 and striving for net-zero emissions by 2050. These targets apply to both Scope 1 and Scope 2 emissions, as outlined in their "Vision 2030" initiative. The company is actively working towards these goals, reflecting a commitment to sustainability and climate responsibility. Overall, CV Sciences, Inc. is focused on reducing its carbon footprint and enhancing its environmental performance, aligning with industry standards and climate action initiatives.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2019202020212022
Scope 1
-
000,000,000
000,000,000
000,000,000
Scope 2
-
000,000,000
000,000,000
000,000,000
Scope 3
24,608,123,000
00,000,000,000
0,000,000,000
00,000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. CV Sciences, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for CV Sciences, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

CV Sciences, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Tilray, Inc. prior to merger with Aphria Inc.

CA
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Cresco Labs Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 8 days ago

Neuropathix, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 29 days ago

Exactus, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 29 days ago

Green Growth Brands Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 29 days ago

Ovation Science Inc.

CA
•
Pharmaceutical Preparation Manufacturing
Updated 29 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250916.2
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy